Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
Report ScopeThe report provides a comprehensive analysis of the bioprocess optimization and digital biomanufacturing market in a global context, including market forecasts and sales through the year 2029. Segmentation based on technology type includes manufacturing technologies (chromatography-based separation and purification, filtration, bioreactors, centrifugation), analytical and process control technologies (spectrophotometry, automation and industrial process control technologies, analytical chromatography, sensors and probes), and software (Industrial control and automation software, bioprocess optimization and data analytics software). Segmentation based on application includes biomanufacturing process automation and control, flexible manufacturing, bioprocess optimization and process analytics, and others. By molecule type the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins and peptides, and cell and gene therapies. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
The report discusses the critical issues impacting the adoption of digital biomanufacturing in pharmaceuticals, as well as emerging trends in digital biomanufacturing technologies. It also features new developments and new product launches in the global market. The report provides comprehensive profiles of market players in the industry. The report also covers mergers and acquisitions and any other collaborations or partnerships that occurred during the evaluation period of this report and which are expected to shape the industry.
Report Includes69 data tables and 61 additional tables
Analyses of trends in the global market for bioprocess optimization and digital bio-manufacturing, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
Estimates of the market size and revenue growth prospects of the global market, along with a market share analysis by technology, application, drug molecule type and region
Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
Analysis of patents, emerging trends, and new developments
Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and ESG scores and practices of leading companies
Profiles of the market leaders, including Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corp., and Sartorius AG.
Companies MentionedAGILENT TECHNOLOGIES INC.
AGILITECH
BIO-RAD LABORATORIES INC.
BRUKER
CLEAN BIOLOGICS
DANAHER CORP.
EMERSON ELECTRIC CO.
EPPENDORF SE
KORBER AG
MERCK KGAA
SARTORIUS AG
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
UNIVERCELLS TECHNOLOGIES
WATERS CORP.